Early cancer detection startup GRAIL nabs over $900 Series B
Menlo Park, California-based GRAIL Inc, an early cancer detection startup, has raised over $900 in the first close of its Series B financing. ARCH Venture Partners led the round with participation from other investors that included Johnson & Johnson Innovation.
3 March 2017•1 min read
